Conserving Scarce Resources: Willingness of Health Insurance Enrollees to Choose Cheaper Options

“OECD Health Data 2002: A Comparative Analysis of 30 Countries” CD-Rom, OECD, Paris 2002.

Zweifel P. and Breyer F.F. , Health Economics (Oxford, New York: Oxford University Press, 1997); Hiatt H.H. , “Protecting the Medical Commons: Who is Responsible?” N. Engl. J. Med. 293, no. 5 (1975): 235–41; Arrow K.J. , “Uncertainty and the Welfare Economics of Medical Care,” Journal of Health, Politics and Policy Law 26, no. 5 (2001): 851–83.

Ubel P. , Pricing Life: Why It's Time for Health Care Rationing (Cambridge, Massachusetts: The MIT Press, 2001).

Hall M.A. , Making Medical Spending Decisions (Oxford: Oxford University Press, 1997).

Levit K. , “Trends in U.S. Health Care Spending, 2001,” Health Affairs 22, no. 1 (2003): 154–64.

Heftier S. , “Health Spending Projections for 2002–2012,” Health Affairs Web Exclusive (February 7, 2003): W3–54 to W3–65, at <http://content.healthaffairs.org/cgi/content/full/hlthaff.w3.54v1/DC1> (last visited August 6, 2004).

Ess S.M. Schneeweiss S. and Szucs T.D. , “European Healthcare Policies for Controlling Drug Expenditure,” PharmacoEconomics 21, no. 2 (2003): 89–103; Jacobson D. , “Effective Strategies for Managing Pharmacy Benefits,” Healthcare Financial Management 55, no. 3 (2001): 41–2.

Ubel P.A. and Goold S.D. , “‘Rationing’ Health Care: Not All Definitions are Created Equal,” Archives of Internal Medicine 158, no. 3 (1998): 209–14; Eddy D.M. , “What Care is ‘Essential’? What Services are 'Basic?” JAMA 265, no. 6 (1991): 782, 786–8.

Danielson P. , “Competition Among Cooperators: Altruism and Reciprocity.” Proceedings of the National Academy of Sciences of the United States of America, 99, Suppl. 3 (2002): 7237–42; Milinski M. Semmann D. and Krambeck H.J. , “Reputation Helps Solve the ‘Tragedy of the Commons,’” Nature 415, no. 6870 (2002): 424–6.

Daniels N. and Sabin J. , “Limits to Health Care: Fair Procedures, Democratic Deliberation, and the Legitimacy Problem for Insurers,” Philosophy of Public Affairs 26, no. 4 (1997): 303–50; Daniels N. Teagarden J.R. Sabin J.E. , “An Ethical Template for Pharmacy Benefits,” Health Affairs 22, no. 1 (2003): 125–37; Emanuel E.J. , “Patient v. Population: Resolving the Ethical Dilemmas Posed by Treating Patients as Members of Populations,” in Danis M. Clancy C.M. and Churchill L. L. , eds. Ethical Dimensions of Health Policy (Oxford, New York: Oxford University Press, 2002): 227–245.

Leibowitz A. Manning W.G. and Newhouse J.P. , “The Demand for Prescription Drugs as a Function of Cost-Sharing,” Social Science and Medicine 21, no. 10 (1985): 1063–9; Rector T.S. , “Effect of Tiered Prescription Co-payments on the Use of Preferred Brand Medications,” Medical Care 41, no. 3 (2003): 398–406; Motheral B. and Fairman K.A. , “Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization,” Medical Care 39, no. 12 (2001): 1293–304; Motheral B. Henderson R. , “The Effect of a Copay Increase on Pharmaceutical Utilization, Expenditures, and Treatment Continuation,” American Journal of Managed Care 5 (November 1999): 1383–94.